Total Funding
75
12
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
515936
CerRx engages in the discovery and development of anticancer drugs such as Fenretinide and Safingol.
Richard L. Love: President & CEO- C. Patrick Reynolds: Chief Scientific Officer
About the Company
CerRx Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide, a synthetic molecule that increases ceramide waxes and kills cancer cells; and Safingol, an artificial ceramide precursor that increases killing of fenretinide in cancer cells. The company was founded in 2008 and is based
in Lubbock, Texas.
